Medical device manufacturer, Baxter, has issued a medical device safety alert concerning its Prismaflex Control Unit. The affected devices in Hong Kong are identified as follows:
According to the manufacturer, due to variability in the performance of the tubing in the ARPS (Automatic Repositioning System) Pump Assembly, which may lead to the following alarm situations during or after a system self-test. Primary alarms may experience "Malfunctions: Prime Self-Test Failure (Code 4) during priming" or "Malfunction: Self-Test Failure (Code 4) during treatment". Secondary alarms may experience "Caution: TMP Excessive" or "Advisory: TMP Too high"
The Prismaflex Control Unit performs system self-tests during priming and at defined intervals during therapy. Therefore, the above alarm situations may occur during priming or during treatment. In these alarm situations, the Prismaflex Control Unit will default to a safe state and provide on-screen instructions to the user. Affected users should follow the on-screen instructions if an alarm appears.
If an alarm occurs, it may lead to delay or interruption of therapy. If therapy is terminated without returning blood to the patient, blood loss may occur. To date, there have been no reports of serious injury potentially associated to this issue in Hong Kong.
To prevent potential alarm situations, the tubing in the ARPS Pump Assembly for the Prismaflex devices will be replaced with improved tubing.
According to the local supplier, the affected products are distributed in Hong Kong.
If you are in possession of the products, please contact your supplier for necessary action.
Posted on 4 February 2021